Contemporary OB-GYN: FDA approves-5-year-use-for-etonogestrel-implant-68-mg-contraceptive Safety Labeling Update for Nexplanon Patient Experiences with Nexplanon Summary of MedWatch Voluntary Reports for Nexplanon (240 reports of device complications for 1,577 reports submitted voluntarily, mainly by consumers) Rare Disease: FDA Approves First Treatment for Children With Menkes Disease The FDA approved the first-ever treatment for Menkes disease: Zydus Life Sciences Zycubo (copper histidinate) daily subcutaneous injection for pediatric patients
Veterinary cognitive health growth and specialty pet care development programs are enhancing demand for processing-grade cognitive supplements throughout companion animal care areas
After menopause, estrogen production by the ovaries declines sharply
AI-based models assess patient-specific parameters, including disease progression, drug kinetics, and real-time physiological responses, to tailor drug administration schedules
Copper peptides are short chains of amino acids bonded with a copper ion
Follow the recommended dosage to stay within safe and effective levels
